FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2727639183> ?p ?o ?g. }

• W2727639183 endingPage "694" @default.
• W2727639183 startingPage "685" @default.
• W2727639183 abstract "Abstract Immune checkpoint blockade using antibodies to cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) benefits a limited number of cancer patients. SS1P and LMB-100 are immunotoxins that target mesothelin. We observed delayed responses to SS1P in patients with mesothelioma suggesting that antitumor immunity was induced. Our goal was to stimulate antitumor immunity by combining SS1P or LMB-100 with anti–CTLA-4. We constructed a BALB/c breast cancer cell line expressing human mesothelin (66C14-M), which was implanted in one or two locations. SS1P or LMB-100 was injected directly into established tumors and anti–CTLA-4 administered i.p. In mice with two tumors, one tumor was injected with immunotoxin and the other was not. The complete regression rate was 86% for the injected tumors and 53% for the uninjetced tumors. No complete regressions occurred when drugs were given separately. In regressing tumors, dying and dead tumor cells were intermingled with PMNs and surrounded by a collar of admixed eosinophils and mononuclear cells. Tumor regression was associated with increased numbers of tumor-infiltrating CD8+ cells and blocked by administration of antibodies to CD8. Surviving mice were protected from tumor rechallenge by 66C14 cells not expressing mesothelin, indicating the development of antitumor immunity. The antitumor effect was abolished when a mutant noncytotoxic variant was used instead of LMB-100, showing that the antitumor response is not mediated by recognition of a foreign bacterial protein. Our findings support developing a therapy composed of immunotoxins and checkpoint inhibitors for patients. Cancer Immunol Res; 5(8); 685–94. ©2017 AACR." @default.
• W2727639183 created "2017-07-14" @default.
• W2727639183 creator A5002583441 @default.
• W2727639183 creator A5010497741 @default.
• W2727639183 creator A5016538112 @default.
• W2727639183 creator A5018642317 @default.
• W2727639183 creator A5026114195 @default.
• W2727639183 creator A5052242334 @default.
• W2727639183 creator A5056265030 @default.
• W2727639183 creator A5056573254 @default.
• W2727639183 creator A5062001972 @default.
• W2727639183 creator A5076748687 @default.
• W2727639183 creator A5090928026 @default.
• W2727639183 date "2017-08-01" @default.
• W2727639183 modified "2023-10-12" @default.
• W2727639183 title "Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Synergistically Eradicates Murine Cancer by Promoting Anticancer Immunity" @default.
• W2727639183 cites W1501027970 @default.
• W2727639183 cites W1521872585 @default.
• W2727639183 cites W1926256541 @default.
• W2727639183 cites W1969194497 @default.
• W2727639183 cites W1978653793 @default.
• W2727639183 cites W1994993231 @default.
• W2727639183 cites W2009720434 @default.
• W2727639183 cites W2014335282 @default.
• W2727639183 cites W2047902191 @default.
• W2727639183 cites W2062715434 @default.
• W2727639183 cites W2066671159 @default.
• W2727639183 cites W2087751238 @default.
• W2727639183 cites W2088482301 @default.
• W2727639183 cites W2092796888 @default.
• W2727639183 cites W2093741293 @default.
• W2727639183 cites W2097995306 @default.
• W2727639183 cites W2100928937 @default.
• W2727639183 cites W2101371847 @default.
• W2727639183 cites W2105017308 @default.
• W2727639183 cites W2128903029 @default.
• W2727639183 cites W2131874142 @default.
• W2727639183 cites W2138746246 @default.
• W2727639183 cites W2141595582 @default.
• W2727639183 cites W2153375051 @default.
• W2727639183 cites W2166662937 @default.
• W2727639183 cites W2201214180 @default.
• W2727639183 cites W2279561773 @default.
• W2727639183 cites W2288933986 @default.
• W2727639183 cites W2560367415 @default.
• W2727639183 cites W2572174216 @default.
• W2727639183 doi "https://doi.org/10.1158/2326-6066.cir-16-0330" @default.
• W2727639183 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5549555" @default.
• W2727639183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28674083" @default.
• W2727639183 hasPublicationYear "2017" @default.
• W2727639183 type Work @default.
• W2727639183 sameAs 2727639183 @default.
• W2727639183 citedByCount "36" @default.
• W2727639183 countsByYear W27276391832017 @default.
• W2727639183 countsByYear W27276391832018 @default.
• W2727639183 countsByYear W27276391832019 @default.
• W2727639183 countsByYear W27276391832020 @default.
• W2727639183 countsByYear W27276391832021 @default.
• W2727639183 countsByYear W27276391832022 @default.
• W2727639183 countsByYear W27276391832023 @default.
• W2727639183 crossrefType "journal-article" @default.
• W2727639183 hasAuthorship W2727639183A5002583441 @default.
• W2727639183 hasAuthorship W2727639183A5010497741 @default.
• W2727639183 hasAuthorship W2727639183A5016538112 @default.
• W2727639183 hasAuthorship W2727639183A5018642317 @default.
• W2727639183 hasAuthorship W2727639183A5026114195 @default.
• W2727639183 hasAuthorship W2727639183A5052242334 @default.
• W2727639183 hasAuthorship W2727639183A5056265030 @default.
• W2727639183 hasAuthorship W2727639183A5056573254 @default.
• W2727639183 hasAuthorship W2727639183A5062001972 @default.
• W2727639183 hasAuthorship W2727639183A5076748687 @default.
• W2727639183 hasAuthorship W2727639183A5090928026 @default.
• W2727639183 hasBestOaLocation W27276391831 @default.
• W2727639183 hasConcept C115085202 @default.
• W2727639183 hasConcept C121608353 @default.
• W2727639183 hasConcept C126322002 @default.
• W2727639183 hasConcept C147483822 @default.
• W2727639183 hasConcept C154317977 @default.
• W2727639183 hasConcept C159654299 @default.
• W2727639183 hasConcept C167672396 @default.
• W2727639183 hasConcept C202751555 @default.
• W2727639183 hasConcept C203014093 @default.
• W2727639183 hasConcept C2777045440 @default.
• W2727639183 hasConcept C2777701055 @default.
• W2727639183 hasConcept C2779341262 @default.
• W2727639183 hasConcept C2780674031 @default.
• W2727639183 hasConcept C2780851360 @default.
• W2727639183 hasConcept C502942594 @default.
• W2727639183 hasConcept C542903549 @default.
• W2727639183 hasConcept C55493867 @default.
• W2727639183 hasConcept C71924100 @default.
• W2727639183 hasConcept C86803240 @default.
• W2727639183 hasConcept C8891405 @default.
• W2727639183 hasConceptScore W2727639183C115085202 @default.
• W2727639183 hasConceptScore W2727639183C121608353 @default.
• W2727639183 hasConceptScore W2727639183C126322002 @default.
• W2727639183 hasConceptScore W2727639183C147483822 @default.
• W2727639183 hasConceptScore W2727639183C154317977 @default.

• next